01368nam2 22002773i 450 VAN004308220221124025815.83920060330d1952 |0itac50 baitaIT|||| |||||ˆ8.2.1: Il ‰contratto di agenziaAldo FormigginiTorinoUnione tipografico-editrice torinese1952110 p.25 cmFondo Tribunale di NapoliIT-IT-CE0105 CONSFTA.196 (8.2.1)Fondo Raffaele PapaIT-IT-CE0105 CONSVI.Ec.83001VAN00048092001 Trattato di diritto civile italianoredatto da diversi giureconsulti sotto la direzione di Filippo Vassalli210 TorinoUnione tipografica editrice torinese215 vol.25 cm.8.2.1TorinoVANL000001FormigginiAldoVANV035131227747UTET <editore>VANV107949650ITSOL20240614RICAVAN0043082BIBLIOTECA DEL DIPARTIMENTO DI GIURISPRUDENZA00CONS FTA.196 (8.2.1) 00FTN6917 20140207 Fondo Tribunale di NapoliBIBLIOTECA DEL DIPARTIMENTO DI GIURISPRUDENZA00CONS VI.Ec.83 00FP 28417 20060419 Fondo Raffaele PapaContratto di agenzia244776UNICAMPANIA02976nam 2200865z- 450 991059507240332120230220(CKB)5680000000080802(oapen)https://directory.doabooks.org/handle/20.500.12854/92146(oapen)doab97463(EXLCZ)99568000000008080220202209d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierNew Insights into the Pathogenesis and Therapies of IgA NephropathyBaselMDPI - Multidisciplinary Digital Publishing Institute20221 online resource (194 p.)3-0365-5041-0 3-0365-5042-9 IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis worldwide and a frequent cause of kidney failure. Better understanding of the pathogenesis of IgAN and the related genetic, immunological, and cellular susceptibility factors are needed to enable the development of effective disease-specific therapy. This book brings together international experts to provide clinical and experimental studies and reviews with an emphasis on early diagnosis, prognosis, disease pathogenesis, determination of disease activity, and new strategies for treatment for IgAN.Medicine and Nursingbicsscaberrantly glycosylated IgA1adultsautoantibodybiomarkerbody mass indexCD38childrenclinical trialscomplementcomplement C3crescentsgalactose-deficient IgA1geneticsglomerular filtration rateglycosylation of IgA1IgAIgA nephropathyIgA NephropathyIgA vasculitisIgA VasculitisIgA1immune complexkidneykidney biopsykidney mesangiumKM55mesangial matrix expansionmouse modeln/anephritisnephrologyO-glycosylationobesityOxford scorephysiopathologyplasma cellspresentationprognosisproteinuriarenal pathologytreatmenturinary galactose-deficient IgA1Medicine and NursingSuzuki Hitoshiedt921974Novak JanedtSuzuki HitoshiothNovak JanothBOOK9910595072403321New Insights into the Pathogenesis and Therapies of IgA Nephropathy3039264UNINA